Poster presentations:

• A Phase 1b Study of Oraxol in Combination with Ramucirumab in Patients with Gastric or Esophageal Cancers who failed previous chemotherapy
• Oral paclitaxel for the treatment of metastatic breast cancer (MBC) patients
• Phase 1 Trial Summary of Encequidar, a Novel P-glycoprotein (P-gp) Inhibitor to Enhance Oral Bioavailability of Chemotherapies
• A pilot study of oral paclitaxel and encequidar in patients with cutaneous angiosarcomas (KX-ORAX-010)